Search

Alois Langer Phones & Addresses

  • 7800 June Dr, Pasadena, MD 21122
  • Harrison City, PA
  • Pittsburgh, PA
  • Jeannette, PA
  • Baltimore, MD
  • Old Bridge, NJ

Work

Company: Cardiac telecom corp Position: Engineer

Education

School / High School: Massachusetts Institute of Technology 1964 to 1967

Industries

Medical Devices

Resumes

Resumes

Alois Langer Photo 1

Engineer

View page
Location:
111 Saddlebrook Dr, Harrison City, PA 15636
Industry:
Medical Devices
Work:
Cardiac Telecom Corp
Engineer
Education:
Massachusetts Institute of Technology 1964 - 1967

Business Records

Name / Title
Company / Classification
Phones & Addresses
Alois Langer
Vice-President
Burglar's Nightmare Locksmith
Repair Services · Locksmith
212 Outlet Way, Greensburg, PA 15601
(724) 837-8284, (724) 221-7987
Alois Langer
Principal
Ctc Corp
Nonclassifiable Establishments
600 Woodside Rd, Pittsburgh, PA 15221
Alois A. Langer
Vice-President, Founder
Cardiac Telecom Corp
Information Technology and Services · Mfg Surgical/Medical Instruments Whol Medical/Hospital Equipment
212 Outlet Way #1, Greensburg, PA 15601
(724) 219-2200

Publications

Us Patents

Biological Targeting Compositions And Methods Of Using The Same

View page
US Patent:
8211656, Jul 3, 2012
Filed:
Aug 13, 2008
Appl. No.:
12/228880
Inventors:
Roderick A. Hyde - Redmond WA, US
Muriel Y. Ishikawa - Livermore CA, US
William Gates - Redmond WA, US
Alois A. Langer - Harrison City PA, US
Eric C. Leuthardt - St. Louis MO, US
Royce A. Levien - Lexington MA, US
Clarence T. Tegreene - Bellevue WA, US
Thomas A. Weaver - San Mateo CA, US
Charles Whitmer - North Bend WA, US
Victoria Y. H. Wood - Livermore WA, US
Assignee:
The Invention Science Fund I, LLC - Bellevue WA
International Classification:
G01N 31/00
G01N 33/53
US Classification:
435 721, 435 71, 436501, 436518, 424 91, 424520, 422 50, 530300, 530350
Abstract:
Modified red blood cells are described. In an embodiment, the modified red blood cell includes a target-binding agent. Targeted delivery of imaging agents, drugs, and peptide and protein pharmaceuticals using modified red blood cells are described. Processes for preparing the modified red blood cells, pharmaceutical and diagnostic compositions containing the same and methods of diagnosis and treatment involving the modified red blood cells are described.

Foam-Like Structures Based On Reactive Composite Materials

View page
US Patent:
8475868, Jul 2, 2013
Filed:
Nov 12, 2008
Appl. No.:
12/291840
Inventors:
Roderick A. Hyde - Redmond WA, US
Muriel Y. Ishikawa - Livermore CA, US
Jordin T. Kare - Seattle WA, US
Alois A. Langer - Pasadena MD, US
Eric C. Leuthardt - St. Louis MO, US
Nathan P. Myhrvold - Medina WA, US
Clarence T. Tegreene - Bellevue WA, US
Charles Whitmer - North Bend WA, US
Richard N. Zare - Stanford CA, US
International Classification:
B05D 5/06
US Classification:
427162, 264 11, 427243, 427244, 427245, 427246, 427247, 427457
Abstract:
Articles having porous or foam-like elements are provided. The design, fabrication and structures of the articles exploit properties of reactive composite materials (RCM) and their reaction products. In particular, fluids generated by reacting RCM are utilized to create or fill voids in the porous or foam-like elements.

Defibrillation System For Non-Medical Environments

View page
US Patent:
20050027317, Feb 3, 2005
Filed:
Jan 23, 2004
Appl. No.:
10/764106
Inventors:
Alois Langer - Harrison City PA, US
International Classification:
A61N001/39
US Classification:
607005000
Abstract:
A defibrillation system having a physiological parameter measuring device for measuring parameters that may indicate a need for a defibrillator; an emergency level detector in communication with the physiological parameter measuring device for detecting emergency level physiological parameters; and a notification device in communication with the emergency level detector for providing notice of the detection of an emergency-level physiological parameter to a caregiver who can then utilize a defibrillator.

Biological Targeting Compositions And Methods Of Using The Same

View page
US Patent:
20100040546, Feb 18, 2010
Filed:
Aug 13, 2008
Appl. No.:
12/228892
Inventors:
Roderick A. Hyde - Redmond WA, US
Muriel Y. Ishikawa - Livermore CA, US
Edward K.Y. Jung - Bellevue WA, US
William Gates - Redmond WA, US
Alois A. Langer - Harrison City PA, US
Eric C. Leuthardt - St. Louis MO, US
Royce A. Levien - Lexington MA, US
Clarence T. Tegreene - Bellevue WA, US
Thomas A. Weaver - San Mateo CA, US
Charles Whitmer - North Bend WA, US
Victoria Y.H. Wood - Livermore CA, US
International Classification:
A61K 49/00
A61K 35/12
C12Q 1/02
A61P 33/00
A61P 31/00
C12Q 1/70
US Classification:
424 91, 424 9373, 435 29, 435 5
Abstract:
Modified red blood cells are described. In an embodiment, the modified red blood cell includes a target-binding agent. Targeted delivery of imaging agents, drugs, and peptide and protein pharmaceuticals using modified red blood cells are described. Processes for preparing the modified red blood cells, pharmaceutical and diagnostic compositions containing the same and methods of diagnosis and treatment involving the modified red blood cells are described.

Biological Targeting Compositions And Methods Of Using The Same

View page
US Patent:
20100041133, Feb 18, 2010
Filed:
Aug 13, 2008
Appl. No.:
12/228868
Inventors:
Roderick A. Hyde - Redmond WA, US
Muriel Y. Ishikawa - Livermore CA, US
Edward K.Y. Jung - Bellevue WA, US
William Gates - Redmond WA, US
Alois A. Langer - Harrison City PA, US
Eric C. Leuthardt - St. Louis MO, US
Royce A. Levien - Lexington MA, US
Clarence T. Tegreene - Bellevue WA, US
Thomas A. Weaver - San Mateo CA, US
Charles Whitmer - North Bend WA, US
Victoria Y.H. Wood - Livermore CA, US
International Classification:
C12N 5/06
US Classification:
435325
Abstract:
Modified red blood cells are described. In an embodiment, the modified red blood cell includes a target-binding agent. Targeted delivery of imaging agents, drugs, and peptide and protein pharmaceuticals using modified red blood cells are described. Processes for preparing the modified red blood cells, pharmaceutical and diagnostic compositions containing the same and methods of diagnosis and treatment involving the modified red blood cells are described.

Biological Targeting Compositions And Methods Of Using The Same

View page
US Patent:
20100042072, Feb 18, 2010
Filed:
Aug 13, 2008
Appl. No.:
12/228893
Inventors:
Roderick A. Hyde - Redmond WA, US
Muriel Y. Ishikawa - Livermore CA, US
Edward K.Y. Jung - Bellevue WA, US
William Gates - Redmond WA, US
Alois A. Langer - Harrison City PA, US
Eric C. Leuthardt - St. Louis MO, US
Royce A. Levien - Lexington MA, US
Clarence T. Tegreene - Bellevue WA, US
Thomas A. Weaver - San Mateo CA, US
Charles Whitmer - North Bend WA, US
Victoria Y.H. Wood - Livermore CA, US
International Classification:
A61M 31/00
A61K 35/18
A61B 18/18
US Classification:
604522, 424 9373, 606 13
Abstract:
Modified red blood cells are described. In an embodiment, the modified red blood cell includes a target-binding agent. Targeted delivery of imaging agents, drugs, and peptide and protein pharmaceuticals using modified red blood cells are described. Processes for preparing the modified red blood cells, pharmaceutical and diagnostic compositions containing the same and methods of diagnosis and treatment involving the modified red blood cells are described.

Foam-Like Structures Based On Reactive Composite Materials

View page
US Patent:
20100104834, Apr 29, 2010
Filed:
Feb 9, 2009
Appl. No.:
12/378086
Inventors:
Roderick A. Hyde - Redmond WA, US
Muriel Y. Ishikawa - Livermore CA, US
Edward K.Y. Jung - Bellevue WA, US
Jordin T. Kare - Seattle WA, US
Alois A. Langer - Pasadena MD, US
Eric C. Leuthardt - St. Louis MO, US
Nathan P. Myhrvold - Medina WA, US
Clarence T. Tegreene - Bellevue WA, US
Charles Whitmer - North Bend WA, US
Richard N. Zare - Stanford CA, US
International Classification:
B32B 7/00
US Classification:
428209, 4281951
Abstract:
Articles having porous or foam-like elements are provided. The design, fabrication and structures of the articles exploit properties of reactive composite materials (RCM) and their reaction products. In particular, fluids generated by reacting RCM are utilized to create or fill voids in the porous or foam-like elements.

Biological Targeting Compositions And Methods Of Using The Same

View page
US Patent:
20120134975, May 31, 2012
Filed:
Aug 13, 2008
Appl. No.:
12/228869
Inventors:
Roderick A. Hyde - Redmond WA, US
Muriel Y. Ishikawa - Livermore CA, US
Edward K.Y. Jung - Bellevue WA, US
William Gates - Redmond WA, US
Alois A. Langer - Harrison City PA, US
Eric C. Leuthardt - St. Louis MO, US
Royce A. Levien - Lexington MA, US
Clarence T. Tegreene - Bellevue WA, US
Thomas A. Weaver - San Mateo CA, US
Charles Whitmer - North Bend WA, US
Victoria Y.H. Wood - Livermore CA, US
International Classification:
A61K 35/18
A61P 31/00
C12N 5/10
A61P 31/10
A61P 33/00
C12N 5/078
A61P 35/00
A61P 31/12
US Classification:
424 9373, 435325, 435 2
Abstract:
Modified red blood cells are described. In an embodiment, the modified red blood cell includes a target-binding agent. Targeted delivery of imaging agents, drugs, and peptide and protein pharmaceuticals using modified red blood cells are described. Processes for preparing the modified red blood cells, pharmaceutical and diagnostic compositions containing the same and methods of diagnosis and treatment involving the modified red blood cells are described.
Alois C Langer from Pasadena, MD, age ~55 Get Report